|
|
Volumn 11, Issue 6, 1997, Pages 490-496
|
|
Metrifonate
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLCHOLINESTERASE;
CHOLINESTERASE;
CHOLINESTERASE INHIBITOR;
DICHLORVOS;
HEXOBARBITAL;
METRIFONATE;
PRODRUG;
ABDOMINAL PAIN;
ALZHEIMER DISEASE;
ARTICLE;
AVOIDANCE BEHAVIOR;
BRAIN TISSUE;
CHOLINERGIC SYSTEM;
CLINICAL TRIAL;
COGNITION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG ABSORPTION;
DRUG CLEARANCE;
DRUG DEGRADATION;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG EXCRETION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG TOLERABILITY;
ENZYME INHIBITION;
ERYTHROCYTE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
LEG CRAMP;
MEMORY;
MUSCLE WEAKNESS;
NAUSEA;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PHARMACODYNAMICS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
VOMITING;
|
|
EID: 0030832997
PISSN: 1170229X
EISSN: None
Source Type: Journal
DOI: 10.2165/00002512-199711060-00008 Document Type: Article |
|
Times cited : (22)
|
|
References (29)
|
